Globus Medical

GMED

Market cap $12B

December momentum picks gain traction as EXPE, ALL, DDS, KGC and GMED stand out after a mixed November.

Stocks like TTWO, GMED, ROK, CNQ and VICI stand out with strong sales growth expectations despite market uncertainty.

This medical products stock breaks out of a cup-with-handle base and is in a buy zone. The company makes technology used for spine surgery.

After reaching an important support level, Globus Medical, Inc. (GMED) could be a good stock pick from a technical perspective. GMED recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

PARR, AU, GMED, ALNT and SNDK emerge as top picks after posting gains, rising estimates and sustained relative price outperformance.

Globus Medical (GMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Globus Medical's spine business is a big earnings driver, propelling its stock closer to a buy point.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Globus Medical has rebounded strongly, driven by accelerating earnings and successful integration of acquisitions like NuVasive and Nevro. The company delivered on robust Q3 results, with 7% organic growth and a significant hike in full-year adjusted earnings guidance to $3.80 per share. Despite a 35% share price surge, shares trades at a reasonable 21x earnings, supported by a strong balance sheet and ongoing synergy potential.